CURRENT STATUS OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER IN PATIENTS TAKING ANTITHROMBOTIC DRUGS

Abstract

Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment published by the Japan Gastroenterological Endoscopy Society in 2012 and guidelines for patients taking anticoagulants additionally published in 2017 include discussions of gastroenterological hemorrhage associated with continuation of antithrombotic therapy, as well as discussions of thromboembolism associated with withdrawal of antithrombotic therapy. In recent studies, the risk of bleeding after gastric endoscopic submucosal dissection remains problematic, especially in patients taking anticoagulants and multiple antithrombotic agents. Patients should be informed of the expected benefits of treatment and the potential complications such as bleeding after gastric endoscopic submucosal dissection.